AposHealth for knee osteoarthritis (HTG671)Product type:GuidanceProgramme:HealthTech guidancePublished: 11 April 2023
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee (TA508)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 7 March 2018
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee (TA477)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 4 October 2017
The EOS 2D/3D imaging system (HTG274)Product type:GuidanceProgramme:HealthTech guidancePublished: 26 October 2011
Autologous chondrocyte implantation using 3D collagen matrix (novocart 3D) for treating articular cartilage defects of the knee [ID2707]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Meniscal Allograft Transplantation for symptomatic meniscal deficient kneeStatus:Topic prioritisationProgramme:Interventional procedures guidanceExpected publication date: TBC
Arthrosamid for symptomatic treatment of knee osteoarthritisStatus:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
The Stak for knee stretching following knee replacement or injury or to treat osteoarthritisStatus:Topic prioritisationProgramme:Medical technologies guidanceExpected publication date: TBC
Vimseltinib for treating tenosynovial giant cell tumours when surgery is unsuitable TSID 12099Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Pimicotinib for treating tenosynovial giant cell tumours when systemic treatment is needed [ID6647]Status:In development | In consultationProgramme:Technology appraisal guidanceConsultation end date: 12 February 2026Expected publication date: TBC